Alexis Coullomb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexis Coullomb has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Vera Pancaldi
Université de Toulouse, INSERM, CNRS, CRCT, Toulouse, France
30 shared publications - Carlos F. Lopez
Altos Labs Bay Area Institute of Technology, Altos Labs, Inc., Redwood City, USA
25 shared publications - Dianna J. Rowe
Vanderbilt University Medical Center, Nashville, TN
25 shared publications - Fabien Maldonado
Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
25 shared publications - Jonathan M. Lehman
Early Global Development, Research and Early Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA
25 shared publications - Jonathan Michael Irish
University of Colorado Anschutz Medical Campus 1 Aurora, CO
25 shared publications
Latest Publications
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Développement de substrats actifs et d'une méthode d'analyse de FRET quantitative pour décoder la mécanotransduction
Les cellules vivantes sont capables de réagir aux signaux mécaniques tels que la rigidité de la surface sur laquelle elles adhèrent, les forces de tractions ou compressions auxquelles elles sont soumises, le flux de liquide à la surface de leur membrane ou encore la géométrie de leurs adhésions ou de leur forme globale. Ces signaux influent sur des processus cellulaires tels que la prolifération, la différenciation, la migration et la mort cellulaire. Ces processus sont finement régulés par des réactions biochimiques qui forment un réseau de signalisation. La mécanotransduction est la traduction du signal mécanique en signal biochimique.C’est dans le but d’étudier la mécanotransduction que nous avons étudié l’utilisation d’ultrasons pour stimuler mécaniquement les cellules à des fréquences temporelles et spatiales relativement élevées. De nombreux montages expérimentaux et de nombreuses voies ont été considérées dans cette partie très exploratoire. Nous en retenons finalement des pistes prometteuses pour la continuation future de ce projet.Nous avons développé ce que nous nommons des substrats actifs, qui nous permettent de contrôler à la fois spatialement et temporellement la stimulation mécanique appliquée à des cellules vivantes. Ces substrats actifs consistent en des micropiliers de fer incrustés dans un élastomère peu rigide (PDMS) et manipulés par deux électroaimants. Nous pouvons contrôler dynamiquement le déplacement des piliers qui vont déformer localement et de manière continue la surface. Cette déformation va ensuite déformer en traction ou en compression les cellules vivantes étalées sur la surface à proximité. En employant des marqueurs fluorescents nous pouvons réaliser de la Microscopie de Forces de Traction et surveiller la contrainte appliquée par les piliers aux cellules à travers la surface de PDMS, et nous pouvons étudier la réponse mécanique des cellules. De plus, ces substrats sont compatibles avec la microscopie de fluorescence en cellule vivante, ce qui rend possible l’observation de la réponse cellulaire au niveau morphologique (forme des adhésions focales, activité protrusive, …) et surtout biochimique.En effet, pour étudier la réponse biochimique des cellules après une stimulation mécanique, nous observons par microscopie de fluorescence des biosenseurs portant des paires de fluorophores donneur/accepteur. Ces biosenseurs nous permettent d’observer l’activité de protéines impliquées dans la signalisation cellulaire en calculant l’efficacité de Transfert d’Énergie Résonnant de Förster (FRET) de ces biosenseurs. Pour ce faire, les échantillons sont illuminés alternativement aux longueurs d’ondes d’excitation des fluorophores donneurs puis accepteurs. Le signal de fluorescence est collecté simultanément dans un canal d’émission du donneur et un canal d’émission de l’accepteur. Une grande partie de ma thèse a été consacrée à la mise au point d’une méthode quantitative pour analyser les images de fluorescence afin de mesurer une efficacité de FRET qui ne dépende pas de facteurs expérimentaux ni de la quantité de biosenseurs présents dans les cellules. Nous évaluons alors les différentes méthodes pour déterminer les facteurs de correction répandus corrigeant le débordement de spectre du donneur dans le canal accepteur et l’excitation directe de l’accepteur à la longueur d’onde d’excitation du donneur. Pour obtenir des mesures plus quantitatives, nous avons mis au point une nouvelles méthode pour déterminer 2 facteurs de correction supplémentaires. Nous comparons cette méthode à la seule préexistante et évaluons l’influence des paramètres de traitement des images sur les valeurs d’efficacité de FRET mesurées.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Développement de substrats actifs et d'une méthode d'analyse de FRET quantitative pour décoder la mécanotransduction
Les cellules vivantes sont capables de réagir aux signaux mécaniques tels que la rigidité de la surface sur laquelle elles adhèrent, les forces de tractions ou compressions auxquelles elles sont soumises, le flux de liquide à la surface de leur membrane ou encore la géométrie de leurs adhésions ou de leur forme globale. Ces signaux influent sur des processus cellulaires tels que la prolifération, la différenciation, la migration et la mort cellulaire. Ces processus sont finement régulés par des réactions biochimiques qui forment un réseau de signalisation. La mécanotransduction est la traduction du signal mécanique en signal biochimique.C’est dans le but d’étudier la mécanotransduction que nous avons étudié l’utilisation d’ultrasons pour stimuler mécaniquement les cellules à des fréquences temporelles et spatiales relativement élevées. De nombreux montages expérimentaux et de nombreuses voies ont été considérées dans cette partie très exploratoire. Nous en retenons finalement des pistes prometteuses pour la continuation future de ce projet.Nous avons développé ce que nous nommons des substrats actifs, qui nous permettent de contrôler à la fois spatialement et temporellement la stimulation mécanique appliquée à des cellules vivantes. Ces substrats actifs consistent en des micropiliers de fer incrustés dans un élastomère peu rigide (PDMS) et manipulés par deux électroaimants. Nous pouvons contrôler dynamiquement le déplacement des piliers qui vont déformer localement et de manière continue la surface. Cette déformation va ensuite déformer en traction ou en compression les cellules vivantes étalées sur la surface à proximité. En employant des marqueurs fluorescents nous pouvons réaliser de la Microscopie de Forces de Traction et surveiller la contrainte appliquée par les piliers aux cellules à travers la surface de PDMS, et nous pouvons étudier la réponse mécanique des cellules. De plus, ces substrats sont compatibles avec la microscopie de fluorescence en cellule vivante, ce qui rend possible l’observation de la réponse cellulaire au niveau morphologique (forme des adhésions focales, activité protrusive, …) et surtout biochimique.En effet, pour étudier la réponse biochimique des cellules après une stimulation mécanique, nous observons par microscopie de fluorescence des biosenseurs portant des paires de fluorophores donneur/accepteur. Ces biosenseurs nous permettent d’observer l’activité de protéines impliquées dans la signalisation cellulaire en calculant l’efficacité de Transfert d’Énergie Résonnant de Förster (FRET) de ces biosenseurs. Pour ce faire, les échantillons sont illuminés alternativement aux longueurs d’ondes d’excitation des fluorophores donneurs puis accepteurs. Le signal de fluorescence est collecté simultanément dans un canal d’émission du donneur et un canal d’émission de l’accepteur. Une grande partie de ma thèse a été consacrée à la mise au point d’une méthode quantitative pour analyser les images de fluorescence afin de mesurer une efficacité de FRET qui ne dépende pas de facteurs expérimentaux ni de la quantité de biosenseurs présents dans les cellules. Nous évaluons alors les différentes méthodes pour déterminer les facteurs de correction répandus corrigeant le débordement de spectre du donneur dans le canal accepteur et l’excitation directe de l’accepteur à la longueur d’onde d’excitation du donneur. Pour obtenir des mesures plus quantitatives, nous avons mis au point une nouvelles méthode pour déterminer 2 facteurs de correction supplémentaires. Nous comparons cette méthode à la seule préexistante et évaluons l’influence des paramètres de traitement des images sur les valeurs d’efficacité de FRET mesurées.
- Open Access
- 26 February 2026
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (5) , 101536
mosna Reveals Different Types of Cellular Interactions Predictive of Response to Immunotherapies and Survival in Cancer
- 26 February 2026
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 25 (5) , 101536
Open Accessmosna Reveals Different Types of Cellular Interactions Predictive of Response to Immunotherapies and Survival in Cancer
- Open Access
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Data from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent (x ≤ 0.4, n = 14), intermediate (0.4 > x ≤ 0.6, n = 27), and aggressive (0.6 > x ≤ 1, n = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention.Significance:This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice.
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Lung adenocarcinoma (LUAD) is a heterogeneous group of tumors associated with different survival rates, even when detected at an early stage. Here, we aim to investigate the biological determinants of early LUAD indolence or aggressiveness using radiomics as a surrogate of behavior. We present a set of 92 patients with LUAD with data collected across different methodologies. Patients were risk-stratified using the CT-based Score Indicative of Lung cancer Aggression (SILA) tool (0 = least aggressive, 1 = most aggressive). We grouped the patients as indolent (x ≤ 0.4, n = 14), intermediate (0.4 > x ≤ 0.6, n = 27), and aggressive (0.6 > x ≤ 1, n = 52). Using Cytometry by time of flight (CyTOF), we identified subpopulations with high HLA-DR expression that were associated with indolent behavior. In the RNA sequencing (RNA-seq) dataset, pathways related to immune response were associated with indolent behavior, while pathways associated with cell cycle and proliferation were associated with aggressive behavior. We extracted quantitative radiomics features from the CT scans of the patients. Integrating these datasets, we identified four feature signatures and four patient clusters that were associated with survival. Using single-cell RNA-seq, we found that indolent tumors had significantly more T cells and less B cells than aggressive tumors, and that the latter had a higher abundance of regulatory T cells and Th cells. In conclusion, we were able to uncover a correspondence between radiomics and tumor biology, which could improve the discrimination between indolent and aggressive LUAD tumors, enhance our knowledge in the biology of these tumors, and offer novel and personalized avenues for intervention.Significance:This study provides a comprehensive profiling of LUAD indolence and aggressiveness at the biological bulk and single-cell levels, as well as at the clinical and radiomics levels. This hypothesis generating study uncovers several potential future research avenues. It also highlights the importance and power of data integration to improve our systemic understanding of LUAD and to help reduce the gap between basic science research and clinical practice.
- Open Access
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 3 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Transcriptomic analysis of LUAD highlights profiles associated with risk stratification. A, Volcano plots for indolent versus aggressive, indolent versus intermediate, and intermediate versus aggressive tumors, showing DEGs by fold change (FC) and P value. Cutoffs are log2FC> |1.5| and P < 0.05 GSEA with Hallmark (B) and REACTOME (C) databases for indolent versus aggressive, indolent versus intermediate, and intermediate versus aggressive tumors. Purple icon indicates pathways upregulated in both indolent and aggressive tumors when compared with intermediate.
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 3 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Transcriptomic analysis of LUAD highlights profiles associated with risk stratification. A, Volcano plots for indolent versus aggressive, indolent versus intermediate, and intermediate versus aggressive tumors, showing DEGs by fold change (FC) and P value. Cutoffs are log2FC> |1.5| and P < 0.05 GSEA with Hallmark (B) and REACTOME (C) databases for indolent versus aggressive, indolent versus intermediate, and intermediate versus aggressive tumors. Purple icon indicates pathways upregulated in both indolent and aggressive tumors when compared with intermediate.
- Open Access
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 1 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Summary of LUAD datasets and study workflow. A, Heat map showing the tissue-based datasets included in this study (rows) by patient (columns) where red means data have been collected for that specific patient and gray that it has not. The bars above the heat map correspond to the number of datasets collected for each patient. The bottom annotation shows some clinical characteristics of the patient cohort. B, Study workflow. Left, For each patient (n = 92), the CT scan taken closest to the day of surgery was retrieved. These were used (i) to calculate the SILA score and stratify the patients; and (ii) to extract a numeric matrix with their radiomics features using the HealthMyne software. Right, When tissue was available for these patients, as described in A, from fresh frozen tissue we collected bulk datasets (in blue) such as RNA-seq and WES, and from single-cell suspension we collected single-cell datasets (in purple) such as CyTOF and single-cell RNA-seq.
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 1 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Summary of LUAD datasets and study workflow. A, Heat map showing the tissue-based datasets included in this study (rows) by patient (columns) where red means data have been collected for that specific patient and gray that it has not. The bars above the heat map correspond to the number of datasets collected for each patient. The bottom annotation shows some clinical characteristics of the patient cohort. B, Study workflow. Left, For each patient (n = 92), the CT scan taken closest to the day of surgery was retrieved. These were used (i) to calculate the SILA score and stratify the patients; and (ii) to extract a numeric matrix with their radiomics features using the HealthMyne software. Right, When tissue was available for these patients, as described in A, from fresh frozen tissue we collected bulk datasets (in blue) such as RNA-seq and WES, and from single-cell suspension we collected single-cell datasets (in purple) such as CyTOF and single-cell RNA-seq.
- Open Access
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 5 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Profiling of LUAD TME by single-cell RNA-seq analysis. A, Uniform Manifold Approximation and Projection (UMAP) representation colored by cell type using all cells (left) and by density grouped by risk group (right). B, UMAP representation colored by gene expression of top lineage gene markers for each main cell type. Reclustering analysis for T cells (C), myeloid cells (D), and B cells (E). UMAP representation colored by cluster, followed by UMAP representation colored by gene expression of some subset representative markers. On the far right, we have UMAP by density grouped by risk group (top) and differential abundance analysis (bottom). Y axis corresponds to the fraction of cells per patient sample. ns, P > 0.05; *, P < 0.05; **, P < 0.001.
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 5 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Profiling of LUAD TME by single-cell RNA-seq analysis. A, Uniform Manifold Approximation and Projection (UMAP) representation colored by cell type using all cells (left) and by density grouped by risk group (right). B, UMAP representation colored by gene expression of top lineage gene markers for each main cell type. Reclustering analysis for T cells (C), myeloid cells (D), and B cells (E). UMAP representation colored by cluster, followed by UMAP representation colored by gene expression of some subset representative markers. On the far right, we have UMAP by density grouped by risk group (top) and differential abundance analysis (bottom). Y axis corresponds to the fraction of cells per patient sample. ns, P > 0.05; *, P < 0.05; **, P < 0.001.
- Open Access
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 1 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Summary of LUAD datasets and study workflow. A, Heat map showing the tissue-based datasets included in this study (rows) by patient (columns) where red means data have been collected for that specific patient and gray that it has not. The bars above the heat map correspond to the number of datasets collected for each patient. The bottom annotation shows some clinical characteristics of the patient cohort. B, Study workflow. Left, For each patient (n = 92), the CT scan taken closest to the day of surgery was retrieved. These were used (i) to calculate the SILA score and stratify the patients; and (ii) to extract a numeric matrix with their radiomics features using the HealthMyne software. Right, When tissue was available for these patients, as described in A, from fresh frozen tissue we collected bulk datasets (in blue) such as RNA-seq and WES, and from single-cell suspension we collected single-cell datasets (in purple) such as CyTOF and single-cell RNA-seq.
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 1 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Summary of LUAD datasets and study workflow. A, Heat map showing the tissue-based datasets included in this study (rows) by patient (columns) where red means data have been collected for that specific patient and gray that it has not. The bars above the heat map correspond to the number of datasets collected for each patient. The bottom annotation shows some clinical characteristics of the patient cohort. B, Study workflow. Left, For each patient (n = 92), the CT scan taken closest to the day of surgery was retrieved. These were used (i) to calculate the SILA score and stratify the patients; and (ii) to extract a numeric matrix with their radiomics features using the HealthMyne software. Right, When tissue was available for these patients, as described in A, from fresh frozen tissue we collected bulk datasets (in blue) such as RNA-seq and WES, and from single-cell suspension we collected single-cell datasets (in purple) such as CyTOF and single-cell RNA-seq.
- Open Access
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 5 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Profiling of LUAD TME by single-cell RNA-seq analysis. A, Uniform Manifold Approximation and Projection (UMAP) representation colored by cell type using all cells (left) and by density grouped by risk group (right). B, UMAP representation colored by gene expression of top lineage gene markers for each main cell type. Reclustering analysis for T cells (C), myeloid cells (D), and B cells (E). UMAP representation colored by cluster, followed by UMAP representation colored by gene expression of some subset representative markers. On the far right, we have UMAP by density grouped by risk group (top) and differential abundance analysis (bottom). Y axis corresponds to the fraction of cells per patient sample. ns, P > 0.05; *, P < 0.05; **, P < 0.001.
- 26 July 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 5 from Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness
Profiling of LUAD TME by single-cell RNA-seq analysis. A, Uniform Manifold Approximation and Projection (UMAP) representation colored by cell type using all cells (left) and by density grouped by risk group (right). B, UMAP representation colored by gene expression of top lineage gene markers for each main cell type. Reclustering analysis for T cells (C), myeloid cells (D), and B cells (E). UMAP representation colored by cluster, followed by UMAP representation colored by gene expression of some subset representative markers. On the far right, we have UMAP by density grouped by risk group (top) and differential abundance analysis (bottom). Y axis corresponds to the fraction of cells per patient sample. ns, P > 0.05; *, P < 0.05; **, P < 0.001.